Medipixel attended Johnson & Johnson’s Talent Acceleration Process (TAP) Residency 3 in Singapore on June 18th and 19th.
After having received first winner prize from J&J’s QuickFire Challenge last year, Medipixel has been under J&J’s acceleration process, and this time’s residency 3 was follow-up of residency 1 in Seoul, Korea, and residency 2 in Bangalore, India. Nine people’s team from J&J has worked on Medipixel’s business model, and come up with a go-to-market strategy that can be feasibly applied to Medipixel’s global market strategy for the coming years.
Andy Song, CEO of Medipixel, said, “J&J’s TAP has been a big help in building global market strategy for Medipixel. Our team started from exploring opportunities, market discovery, business model hypothesis, and moved on ideation, and implementation. J&J and Medipixel have worked on this procedure for about 4 months, and I’m sure this will make a difference for Medipixel to see the market in a feasible way.”. The team will have final gathering in July for reviewing the final document.